Over 60,000 people died from drug overdoses in 2016. Chairman and CEO of hc1.com Brad Bostic compares this to six fully loaded jets crashing each month.
hc1.com is a healthcare management platform headquartered in the Northwest Technology Center in southeast Zionsville and northwest Indianapolis.
The company announced in late November their new hc1 Opioid Dashboard – a cloud-based information service that applies artificial intelligence to various healthcare datasets.
Through the relationships built over the past six years since its inception, hc1 streamlined data from different lab locations, healthcare providers, healthcare facilities, home health agencies, hospice providers and others to launch a live dashboard that shows drug positivity rates in specific geographic areas. Then, the dashboard relates this information to factors like demographics, drug prescriptions, addiction programs, etc.
The Opioid Dashboard is designed for a mix of companies including state and federal government agencies, healthcare providers, pharmacies and payers.
“We are in a very unique position to help become more proactive around this issue because of the fact that we have many, many resources of information that we have uniquely organized into this very clear view,” Bostic said.
How does the dashboard work?
Bostic compared the dashboard to a weather map.
“You would never consider not looking at the forecast,” he said. “You would always say, ‘Hey, I want to know if there’s a hurricane coming.’ I need to know that so I can prepare.”
In the example shown, the dashboard shows the positivity rate by Indiana county and Boone County is red which is the highest level of concentration. The positivity rate is based on usage of different drugs that is on board with different healthcare systems, not just in one arena but in various venues like workforce settings, regulated industries, the criminal justice system, pain management, etc.
The dashboard looks at things like what kinds of drugs people are being prescribed, the amount of pain management drugs, and the different screening types.
Indiana is just one example of the national platform. The entire data set pulls from 5 billion diagnostic results from thousands of lab locations, using information from over 51 million individuals, across 3.8 million providers.
Bostic described the program as de-identified information and analytics and dashboards that can help inform on how to more effectively tackle the crisis.
The dashboard not only tracks opioids but other drugs like benzos and fentanyl – which has seen a significant uptick in usage recently.
For more information, go to hc1.com/solutions/opioid-dashboard.
See Wednesday's Times Sentinel for full story.